🟢 Ocugen rises 6.2% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism

With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise.

The biotechnology sector, as measured by the XBI ETF, is trading significantly higher today, driven by a positive outlook from industry bellwether Thermo Fisher Scientific. The company reported strengthening demand from pharmaceutical and biotech customers, citing increased investment in R&D and a healthier funding environment. This news, coupled with ongoing optimism around M&A activity and a receptive IPO market, is fueling investor confidence in the sector's growth prospects.